Author

Ling Lian

Cleveland ClinicORCID 0000-0002-6431-5154Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ling Lian1 paper

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aleph Prieto· 1 shared Gunnar H.D. Poplawski· 1 shared Hayley Robinson· 1 shared Noah J. DanielsiD· 1 shared Rodrigo Lopez-GonzaleziD· 1 shared SK Imran Ali· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aleph Prieto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell cycle dysregulation contributes to neurodegeneration in humanneurons from ALS/FTD-related C9orf72 repeat expansion carriers.

SK Imran Ali, Ling Lian, Hayley Robinson, Noah J. Daniels, Aleph Prieto, Gunnar H.D. Poplawski, Rodrigo Lopez-Gonzalez

This study identifies cell cycle dysregulation as a therapeutic target in C9orf72 ALS/FTD using iPSC-derived neurons and shows that CDK4/6 inhibition rescues neuronal survival.

bioRxiv · Jun 4, 2025 · PreprintNeuroscience